Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients

Experimental and Clinical Transplantation

Volumn 10, Issue 3, 2012, Pages 278-281

  Tabarsi, Payam ^a   Soraghi, Abdolreza ^a   Marjani, Majid ^a   Zandian, Paris ^a   Baghaei, Parvaneh ^a   Najafizadeh, Katayoon ^a   Droudinia, Atoosa ^a   Sarrafzadeh, Shokooh Azam ^b   Javanmard, Pedram ^a   Mansouri, Davood ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aspergillosis; Bronchoalveolar lavage; Fungal; Galactomanam; Transplantation

Indexed keywords

GALACTOMANNAN;

ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; FUNGAL DETECTION; FUNGUS CULTURE; GALACTOMANNAN BLOOD LEVEL; GRAFT RECIPIENT; HEART LUNG TRANSPLANTATION; HUMAN; INVASIVE ASPERGILLOSIS; LUNG INFECTION; LUNG LAVAGE; MALE; PREDICTIVE VALUE; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIFUNGAL AGENTS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; DRUG THERAPY, COMBINATION; ECHINOCANDINS; HEART TRANSPLANTATION; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG TRANSPLANTATION; MALE; MANNANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PYRIMIDINES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION; TRIAZOLES;

EID: 84862619477     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2011.0176     Document Type: Article

References (16)

1. De Vlieger G, Lagrou K, Meersseman W. Galactomannan detection in nonserum specimens: Where do we stand? Curr Fungal Infect Rep. 2011;3(4):201-206.
2. Patterson TF. Advances and challenges in management of invasive mycoses. Lancet. 2005;366(9490):1013-1025.
3. Verweij PE, Denning DW. The challenge of invasive aspergillosis: Increasing numbers in diverse patient groups. Int J Infect Dis. 1997;2(2):61-63.
4. Fortun J, Martin-Davila P, Alvarez ME, et al. Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients. Transplantation. 2001;71(1):145-149.
5. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42(10):1417-1427.
6. Silveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med. 2008;14(3):211-218.
7. Husain S, Paterson DL, Studer SM, et al. Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients. Transplantation. 2007;83(10):1330-1336.
8. Clancy CJ, Jaber RA, Leather HL, et al. Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients. J Clin Microbiol. 2007;45(6):1759-1765.
9. Segal BH. Aspergillosis. N Engl J Med. 2009;360(18):1870-1884.
10. Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest. 2010;138(4):817-824.
11. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.
12. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008;177(1):27-34.
13. Park SY, Lee SO, Choi SH, et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect. 2010;61(6):492-498.
14. Patterson TF. Risk stratification for invasive aspergillosis: early assessment of host susceptibility. Med Mycol. 2009;47(suppl 1):S255-S260.
15. Sarrafzadeh SA, Hoseinpoor Rafati A, Ardalan M, Mansouri D, Tabarsi P, Pourpak Z. The accuracy of serum galactomannan assay in diagnosing invasive pulmonary aspergillosis. Iran J Allergy Asthma Immunol. 2010;9(3):149-155.
16. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7-14.